SYNOPSIS Previous electrophoretic methods for the separation of tissue-specific serum alkaline phosphatases have either been unable to separate the liver and bone enzymes or have been too involved for routine clinical use. A relatively simple electrophoretic method is described which separates placental, liver, bone, and intestinal alkaline phosphatases in serum. The clinical applications of such a method appear to be mainly in the differential diagnosis of liver and bone disease, especially in complicated hypercalcaemic states where tumour metastases can affect both bone and liver, in children, and possibly in cirrhosis of the liver.
Alkaline phosphatase activity in human serum is derived from liver, bone, intestine, or placenta. In hepatobilary and osteoblastic bone disease the increase in total serum alkaline phosphatase activity is due to the release of tissue-specific liver and bone alkaline phosphatase into the serum. In a clinical context the significance of a raised serum enzyme level is usually obvious, but the potential value of identifying the tissue or tissues responsible for the rise, and of establishing their respective contribution to the total increase, has long been recognized. A method for doing this and our experience with the method in routine clinical practice is described in the present paper.
Material and Methods
Sera from 186 subjects were analysed. They were Received for publication 22 December 1969. divided on clinical grounds into eight groups as shown in Table I .
Total serum alkaline phosphatase activity was estimated by a routine adaptation of the method of Babson (1965) using phenolphthalein monophosphate as the substrate. Alkaline phosphatase activities are expressed in King-Armstrong units per 100 ml (K-A u %).
established liver and bone disease. The groups of pregnant women and old people are compared with the normal adult group. The results from the group of sick children are compared with those obtained from normal children.
Using the method described below zones of alkaline phosphatase activity extracted from liver, bone, placenta, or gut had similar mobilities to the corresponding zones of serum activity. Patients with oesteoblastic bone disease (Table III) Patient with hepatobiliary disease with hyperbilirubinaemia (Table IV) Normal adults aged 18 to 56 years (Table V) Pregnant women in the last trimester (Table Vt) Normal children aged 2 to 14 years (Table VII) Sick children aged I day to 12 years (Table VIII) Old people aged over 75 years with evidence of osteoporosis (Table IX) Patients for diagnosis ( Electrophoresis was carried out on vertical polyacrylamide gel slabs, essentially as described by Akroyd (1967) . The dimensions of the cell were 16 x 10 x 0-3 cm.
Forty ml of 8% Cyanogum 41 (acrylamide monomer plus N N'-methylene-bis-acrylamide, British Drug Houses Ltd) in Tris-citrate buffer, plus 0-2 ml fl-dimethylaminopropionitrile, and 0 3 ml 7% ammonium persulphate was pipetted into the cell, overlaid with distilled water, and allowed to set. In mixing these substances, as far as possible contact with the air was avoided.
The composition of the Tris-citrate 'gel' buffer (pH 8-8) was 1 52 ml 2 M Tris-(hydroxymethyl)-aminomethane plus 0-2 ml 1 M citric acid made up to 40 ml with distilled water. The electrode compartment buffer (pH 8'8) was 60 ml 0-5 M boric acid plus 4-5 ml 2-5 M sodium hydroxide made up to 1 litre with distilled water.
Some improvement in the resolution between the various alkaline phosphatase zones, especially when assaying sera with normal alkaline phosphatase levels, could be achieved by adding a 'spacer' gel to the system. This was done by gelling 35 ml 8% Cyanogum 41 as described above, removing the excess liquid, and adding 5 ml 4% gel solution. This was similarly overlaid with water and allowed to set.
Temporary sample compartments were made along the upper surface of the gel by inserting small pieces of Teflon tubing, approximately 5 mm in length, until they sat firmly on the upper surface of the gel, which was washed several times with water and left filled with water. Samples, prestained with bromphenol blue, were pipetted into the compartments. A 1 5-mA constant current was passed until the samples had just migrated into the gel. The current was turned off while the sample compartments were removed. When this was completed the wick was replaced, and electrophoresis at 30 mA constant current was continued until one and a half hours after the albumin bands had migrated out of the bottom of the gel. The gel was then removed from the cell and zones of alkaline phosphatase activity were located by incubating the gel in a solution of sodium 2-naphthyl phosphate and fast blue BB (F. T. Gurr Ltd) in the dark, at room temperature, at pH 9-7 (Smith et al, 1968) until staining was optimal. This time was usually up to two hours. Low activity samples can be incubated in two changes of 'location' reagent to increase the intensity of staining.
To localize zones of alkaline phosphatase activity to specific serum protein fractions duplicate samples were run side by side on the same gel (Fig. 1) . After electrophoresis the gel was sliced, one duplicate being stained with Lissamine Light Green and cleared in dilute acetic acid for total protein, and the other for alkaline phosphatase activity as described above. Both strips were then left overnight in dilute acetic acid to attain the same degree of shrinkage 1  100  73  27  75  25  75  25  70  30  80  20  2  110  57  43  60  40  60  40  60  40  65  35  3  130  40  60  40  60  40  60  45  55  40  60  4  150  25  75  30  70  35  65  40  60  20  80  5  150  25  75  30  70  35  65  35  65  20 6 Male aged 42 years (AP = 6 K-A u%Y.). a gel on which had been run eight sgmples with total alkaline phosphatase activities varying between 15 and 150 K-A u %. The samples contained different proportions of liver and bone alkaline phosphatase from 25 to 75 % of the total activity. The subjects were asked to assess the proportions of the two zones in each sample.
Results
The mobilities of the major zones of alkaline phosphatase activity occurring in serum in relation to other serum protein fractions are shown in Figure 1 . In 8% polyacrylamide all major zones of activity run in a region between transferrin and the beta-globulin-gamma-globulin complex. Placental alkaline phosphatase travels. farthest, followed by that of liver, bone, and intestine in that order. In 5 % polyacrylamide the mobility of all the serum alkaline phosphatase zones is increased relative to transferrin, and they migrate in a region in front of, and behind, transferrin (unpublished results).
The validity of visual assessment as a measure of the relative intensities of zones of alkaline phosphatase is shown in Table II . No assessment varied by more than 15 % of the calculated percentage, and most assessments were accurate to within ± 5 %.
Results obtained from a reference series of 16 patients with osteoblastic bone disease are summarized in Table III . These patients were suffering from osteomalacia, vitamin D-resistant rickets, nutritional rickets, or Paget's disease. Their total serum alkaline phosphatase activities were between 16 and 108 K-A u %, of which the serum bone zone seen after electrophoresis was not less than 85 % of the total activity. The remainder of the activity was of liver type.
A summary of the results obtained on a reference series of 16 patients with hepatobiliary disease and hyperbilirubinaemia is given in Table IV. All these subjects had a raised serum alkaline phosphatase activity which, in 15 of the cases, was of liver type only. One serum was also found to contain a zone of bone alkaline phosphatase. The level of activity in this zone was within the limits for bone activity seen in adult normals.
The results in a reference series of 31 normal adults are shown in Table V . The total serum alkaline phosphatase activity was between 4 and 8 K-A u %. Both liver and bone zones were seen in all these subjects. Variations in the proportions of alkaline phosphatase in individual sera appeared to be random with regard to age and sex, and varied between 15 and 90% for liver and between 10 and 85 % for bone (Fig. 2) . Intestinal alkaline phosphatase activity was seen in six female and four male subjects, and in one case (no. 29) accounted for 40% of the total activity. Further evidence that intestine was the tissue of origin of this zone was given by the addition of L-phenylalanine (0005 M) to the incubation solution after electrophoresis. This resulted in specific inhibition of the serum intestinal alkaline phosphatase activity (Fishman, Green, and Inglis, 1963 Electrophoretic separation of tissue-specific serum alkaline phosphatases intestinal, or placental alkaline phosphatase Although we are satisfied that the technique (Posen, Neale, and Clubb, 1965 (Hill and Sammons, 1967; Newton, 1967 
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The significance of serum alkaline phosphatase activities depends, in part, on the age of the subject. Like earlier workers we find that the total serum alkaline phosphatase activity of children is significantly higher than that of normal adults (Clark and Beck, 1950) . Electro- phoretic fractionation shows that this difference is due entirely to the higher bone activity in childhood. Our findings in a somewhat heterogenous series of sick children suggest that in this age group fractionation of serum alkaline phosphatase might prove particularly useful in revealing an abnormally low bone alkaline phosphatase activity. This appears to be a common accompaniment of a variety of acute systemic illnesses, and it may prove a sensitive indication of arrest of osteoblastic activity and bone growth. Such an index of decreasing osteoblastic activity might be particularly useful in assessing the effect of steroid treatment on children. A fall in bone alkaline phosphatase activity can be masked by a rise in liver activity if only the total serum activity is measured (cases 7 to 9, Table VIII ). Conversely, a significant rise in liver alkaline phosphatase activity can be missed because of a synchronous fall in bone activity (cases 12 to 14, Table VIII ). This fact has been used in the past to question the usefulness of estimations of serum alkaline phosphatase activity in children (Hobbs, Campbell, and Scheuer, 1968 (Table X) .
2 Osteomalacia (AP 31 K-A u%) in case 4 (Table III) .
3 Normal child (AP = 24 K-A u%) in case 5 (Table VII) .
4 Mixture ofplacental, liver, bone, and intestinal tissue extracts. (Table IV) .
7 Late pregnancy (AP = 18 K-A u%) in case 5 (Table VI) .
when coupled with electrophoretic fractionation, such studies can, in fact, be of value.
At the other extreme of life, we were unable to confirm reports by earlier workers that old people, and in particular old women, have significantly higher serum alkaline phosphatase activities than normal adults (Heino and Jokipii, 1962; Klaassen and Siertsema, 1964 Routine fractionation of alkaline phosphatase has also raised a number of questions which we had not previously envisaged and which require further study. Four patients with known or suspected liver disease (cases 25 to 28, Table X) showed, in addition to a liver band, a marked intestinal band of alkaline phosphatase. All proved on subsequent investigation to be cases of liver cirrhosis. Since an intestinal band is apparently not a feature of other types of liver disease, this may prove to be an exceptional instance of disease as well as organ specificity. The Lewis blood group and secretor status of these patients was not determined.
In agreement with other workers (Gutman, Tyson, and Gutman, 1936) we find that the level of serum bone alkaline phosphatase activity in cases where there are secondary osteolytic carcinomatous deposits bears little relation to the degree of bone involvement as assessed radiologically or clinically.
It is well known that total serum alkaline phosphatase activity is raised in the later stages of pregnancy and that this increase is due to the appearance of placental alkaline phosphatase in the serum. This placental component (Fig. 3) can be readily demonstrated by electrophoresis (Boyer, 1961 (Table X) . These children had clinical evidence of bone disease but their total serum alkaline phosphatase levels were within normal limits for their age. The electrophoretic patterns seen in these cases were indistinguishable from those of normal children.
It might be argued that, whatever the intrinsic academic interest of serum enzymefractionation, the technique is an unnecessary refinement for routine day-to-day diagnosis. From our experience we would disagree. As a group of diagnostic procedures, serum enzyme estimations have many disadvantages compared with older, more conventional chemical tests. These disadvantages are offset by two advantages. First, the estimations are potentially highly specific. Secondly, they can be extremely sensitive indicators of disease activity. Total serum alkaline phosphatase estimations lack both specificity and sensitivity: the results may not only fail to provide the required information, they may even mislead. This is particularly so when a raised serum alkaline phosphatase level is the only abnormal laboratory finding in a patient complaining of ill defined symptoms-a not uncommon occurrence. Coupling the total serum alkaline phosphatase estimation with a sensitive fractionation technique makes the estimation a reliable and specific indicator of disease.
